Pre-existing chikungunya virus neutralizing antibodies correlate with risk of symptomatic infection and subclinical seroconversion in a Philippine cohort
Background: A longitudinal cohort study performed in Cebu City, Philippines found that the presence of pre-existing chikungunya virus (CHIKV) neutralizing antibodies (NAb) was associated with a decreased risk of symptomatic CHIKV infection. However, the relationship between pre-existing NAb and the...
Main Authors: | In-Kyu Yoon, Anon Srikiatkhachorn, Maria Theresa Alera, Stefan Fernandez, Derek A.T. Cummings, Henrik Salje |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S120197122030206X |
Similar Items
-
Assessing correlates of protection in vaccine trials: statistical solutions in the context of high vaccine efficacy
by: Andrea Callegaro, et al.
Published: (2019-03-01) -
Development of Neutralization Assay Using an eGFP Chikungunya Virus
by: Cheng-Lin Deng, et al.
Published: (2016-06-01) -
Surrogate endpoint evaluation using data from one large global randomized controlled trial
by: Milan Geybels, et al.
Published: (2021-05-01) -
Resolution of a Chikungunya Outbreak in a Prospective Cohort, Cebu, Philippines, 2012–2014
by: Anon Srikiatkhachorn, et al.
Published: (2016-10-01) -
Patient Centered Outcomes in Periodontal Treatment-An Evidenced Based Approach
by: Ekta Bharatbhai Shah, et al.
Published: (2017-04-01)